Skip to main content
. Author manuscript; available in PMC: 2019 Apr 26.
Published in final edited form as: J Biol Inorg Chem. 2010 Mar 7;15(5):677–688. doi: 10.1007/s00775-010-0635-0

Figure 2.

Figure 2

ESI TOF mass spectra showing the interactions between DS3 and platinum-based chemotherapeutics. Top: unmodified DS3. Middle: DS3+cisplatin (incubation with carboplatin yields the same adducts albeit in lower relative intensity). Bottom: DS3+oxaliplatin.